PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Klaeger, S.* ; Heinzlmeir, S.* ; Wilhelm, M.* ; Polzer, H.* ; Vick, B. ; Koenig, P.A.* ; Reinecke, M.* ; Ruprecht, B.* ; Petzoldt, S.* ; Meng, C.* ; Zecha, J.* ; Reiter, K.* ; Qiao, H.* ; Helm, D.* ; Koch, H.* ; Schoof, M.* ; Canevari, G.* ; Casale, E.* ; Depaolini, S.R.* ; Feuchtinger, A. ; Wu, Z.* ; Schmidt, T.* ; Rueckert, L.* ; Becker, W.* ; Huenges, J.* ; Garz, A.K.* ; Gohlke, B.O.* ; Zolg, D.P.* ; Kayser, G.* ; Vooder, T.* ; Preissner, R.* ; Hahne, H.* ; Tõnisson, N.* ; Kramer, K.* ; Götze, K.* ; Bassermann, F.* ; Schlegl, J.* ; Ehrlich, H.C.* ; Aiche, S.* ; Walch, A.K. ; Greif, P.A.* ; Schneider, S.* ; Felder, E.R.* ; Ruland, J.* ; Médard, G.* ; Jeremias, I. ; Spiekermann, K.* ; Kuster, B.*

The target landscape of clinical kinase drugs.

Science 358:eaan4368 (2017)
Publ. Version/Full Text Postprint Research data DOI PMC
Open Access Green
Kinase inhibitors are important cancer therapeutics. Polypharmacology is commonly observed, requiring thorough target deconvolution to understand drug mechanism of action. Using chemical proteomics, we analyzed the target spectrum of 243 clinically evaluated kinase drugs. The data revealed previously unknown targets for established drugs, offered a perspective on the "druggable" kinome, highlighted (non)kinase off-targets, and suggested potential therapeutic applications. Integration of phosphoproteomic data refined drug-affected pathways, identified response markers, and strengthened rationale for combination treatments. We exemplify translational value by discovering SIK2 (salt-inducible kinase 2) inhibitors that modulate cytokine production in primary cells, by identifying drugs against the lung cancer survival marker MELK (maternal embryonic leucine zipper kinase), and by repurposing cabozantinib to treat FLT3-ITD-positive acute myeloid leukemia. This resource, available via the ProteomicsDB database, should facilitate basic, clinical, and drug discovery research and aid clinical decision-making.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
37.205
7.688
322
386
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Integrative Genomics Viewer; Salt-inducible Kinases; Chemical Proteomics; Inhibitor Selectivity; Comprehensive Analysis; Data Quality; Protein; Quantification; Refinement; Cancer
Language english
Publication Year 2017
HGF-reported in Year 2017
ISSN (print) / ISBN 0036-8075
e-ISSN 1095-9203
Journal Science
Quellenangaben Volume: 358, Issue: 6367, Pages: , Article Number: eaan4368 Supplement: ,
Publisher American Association for the Advancement of Science (AAAS)
Publishing Place Washington
Reviewing status Peer reviewed
Institute(s) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
CF Pathology & Tissue Analytics (CF-PTA)
Research Unit Analytical Pathology (AAP)
POF-Topic(s) 30204 - Cell Programming and Repair
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
Research field(s) Stem Cell and Neuroscience
Enabling and Novel Technologies
PSP Element(s) G-506600-001
A-630600-001
G-500390-001
DOI 10.1126/science.aan4368
WOS ID WOS:000416584000032
Scopus ID 85036597195
PubMed ID 29191878
Erfassungsdatum 2017-12-04
[➜Report correction]